amphetamine has been researched along with amantadine in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 48 (81.36) | 18.7374 |
1990's | 2 (3.39) | 18.2507 |
2000's | 4 (6.78) | 29.6817 |
2010's | 5 (8.47) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gianutsos, G; Hane, JT; Henkel, JG | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Bedwell, DW; Higgins, JW; Zamek-Gliszczynski, MJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cunnane, T; Draper, AJ; Redfern, PH | 1 |
Cox, B; Kastin, AJ; Schnieden, H | 1 |
Ho, IK; Iwamoto, ET; Khanna, S; Loh, HH; Shen, F; Way, EL | 1 |
Dinnendahl, V; Gumulka, SW; Peters, HD; Schönhöfer, PS | 1 |
Goldberg, LI | 1 |
Lazarova, M; Roussinov, K | 2 |
Agnoli, A; Squitieri, G | 1 |
Breddin, K; Jarosch, U; Lemmer, B | 1 |
Bartholini, G; Haefely, W; Pletscher, A | 1 |
Perez, N; Pita, E | 1 |
Lapin, IP; Patkina, NA | 1 |
Comes, L; Cuparencu, B; Danau, M; Safta, L | 1 |
Bergen, D; Goetz, C; Klawans, HL | 1 |
Asselman, P; Bovill, KT; Marsden, CD; Parkes, JD; Phipps, JA; Rose, P; Tarsy, D | 1 |
Bailey, EV; Stone, TW | 1 |
Bariletto, S; Dollar, E; Leitz, F | 1 |
Stone, TW | 1 |
Dandiya, PC; Kulkarni, SK | 1 |
Bhalla, S; Mehta, VL; Wafai, ZA | 1 |
Moore, KE; Von Voigtlander, PF | 2 |
Moore, KE; Thornburg, JE | 2 |
Enna, SJ; Shore, PA | 1 |
Beyer, J; Philippu, A | 1 |
Costall, B; Naylor, RJ | 2 |
Stromberg, U; Svensson, TH; Waldeck, B | 1 |
Calne, DB; Reid, JL | 1 |
Fennessy, MR; Heimans, RL; Rand, MJ | 1 |
Eigeman, L; Vaatstra, WJ | 1 |
Howes, J; Osgood, P | 1 |
Duvoisin, RC; Yahr, MD | 1 |
Tolosa, E | 1 |
Bianchine, JR; Sunyapridakul, L | 1 |
Lassen, JB | 1 |
Lemmer, B | 1 |
Beani, L; Bianchi, C | 1 |
Cashin, CH; Sutton, S | 1 |
Grabowska, M | 1 |
Beani, L; Bianchi, C; Cartei, M; Gomirato, G; Perfetti, C | 1 |
De Carolis, AS; Del Basso, P; Longo, VG; Ziegler, H | 1 |
Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
Bönisch, H; Rodrigues-Pereira, E | 1 |
Westermann, KH | 1 |
Kleinrok, Z; Szurska, G | 1 |
Fisher, H; Goldberg, M; Mirovsky, Y; Sekowski, A; Wagner, GC; Yu, YL | 1 |
Browning, RG; Merigian, KS | 1 |
Auerbach, PP; Cadenhead, K; Eastvold, A; Geyer, MA; Karban, B; Ploum, Y; Stephany, N; Swerdlow, NR | 1 |
Dziedzicka-Wasylewska, M; Faron-Górecka, A; Rogóz, Z; Solich, J | 1 |
Bezard, E; Björklund, A; Carta, M; Li, Q; Pioli, EY; Porras, G; Tronci, E | 1 |
Adams, WK; Kaur, S; Lam, FC; Muthukrishna, M; Riparip, LK; Rosi, S; Vonder Haar, C; Winstanley, CA | 1 |
8 review(s) available for amphetamine and amantadine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Memory, biochemical and pharmacological problems].
Topics: Amantadine; Amphetamine; Brain; Catecholamines; Humans; Levodopa; Memory, Short-Term; Paired-Associate Learning; Physostigmine; Reserpine | 1977 |
Monoaminergic drugs: general pharmacology.
Topics: Absorption; Amantadine; Amphetamine; Animals; Apomorphine; Brain; Catecholamines; Cats; Cattle; Deamination; Decarboxylation; Dogs; Half-Life; Haplorhini; Humans; Hydroxylation; Kinetics; Levodopa; Methylation; Mice; Rats | 1976 |
Antiparkinsonian drugs: pharmacological and therapeutic aspects.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Histamine H1 Antagonists; Humans; Mental Disorders; Methyldopa; Movement Disorders; Norepinephrine; Parasympatholytics; Serotonin; Synaptic Transmission | 1972 |
Drug therapy of parkinsonism.
Topics: Amantadine; Amitriptyline; Amphetamine; Antiparkinson Agents; Dihydroxyphenylalanine; Drug Antagonism; Drug Synergism; Humans; Imipramine; Methyldopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Phenothiazines | 1972 |
Parkinson's disease; modern treatment.
Topics: Amantadine; Amphetamine; Antidepressive Agents; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Catechol O-Methyltransferase Inhibitors; Desipramine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Drug Incompatibility; Drug Synergism; Humans; Imipramine; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease | 1973 |
Individualization of levodopa therapy.
Topics: Amantadine; Amphetamine; Anesthetics; Animals; Antihypertensive Agents; Apomorphine; Arrhythmias, Cardiac; Carbidopa; Depression, Chemical; Diet; Disulfiram; Drug Interactions; Drug Therapy, Combination; Endocrine Glands; Glaucoma; Humans; Hydrogen-Ion Concentration; Levodopa; Mice; Parasympatholytics; Parkinson Disease; Stomach | 1974 |
[Compounds stimulating central catecholamine receptors].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Catecholamines; Clonidine; Dopamine; Extrapyramidal Tracts; Humans; Mice; Norepinephrine; Rats; Receptors, Adrenergic; Receptors, Drug; Stereotyped Behavior; Stimulation, Chemical | 1973 |
1 trial(s) available for amphetamine and amantadine
Article | Year |
---|---|
Amphetamines in the treatment of Parkinson's disease.
Topics: Aged; Amantadine; Amphetamine; Clinical Trials as Topic; Female; Humans; Isomerism; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Parkinson Disease, Postencephalitic; Posture; Structure-Activity Relationship; Tremor | 1975 |
50 other study(ies) available for amphetamine and amantadine
Article | Year |
---|---|
Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution.
Topics: Amantadine; Animals; Antiparkinson Agents; Mice; Motor Activity; Receptors, Dopamine; Structure-Activity Relationship | 1982 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Topics: Animals; Kidney; Liver; Male; Metformin; Mice; Mice, Knockout; Octamer Transcription Factor-1; Organic Cation Transport Proteins; Organic Cation Transporter 2; Tissue Distribution | 2012 |
Proceedings: The effects of amantadine, tranylcypromine, amphetamine and tyramine on the response of the rat anococcygeus muscle after bretylium.
Topics: Amantadine; Amphetamine; Animals; Bretylium Compounds; Electric Stimulation; In Vitro Techniques; Muscle Contraction; Muscles; Norepinephrine; Rats; Tranylcypromine; Tyramine | 1975 |
A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Body Temperature; Brain; Dopamine; Female; Humans; Levodopa; Mice; Motor Activity; MSH Release-Inhibiting Hormone; Rats; Receptors, Drug; Stereotyped Behavior; Time Factors | 1976 |
Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hydrazines; Iproniazid; Male; Mice; Mice, Inbred ICR; Morphine Dependence; Motor Activity; Naloxone; Pargyline; Substance Withdrawal Syndrome; Time Factors; Tranylcypromine | 1976 |
Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Benserazide; Brain; Cerebellum; Cyclic AMP; Cyclic GMP; Dopamine; Dose-Response Relationship, Drug; Humans; Isoquinolines; Levodopa; Male; Mice; Nucleotides, Cyclic; Stereotyped Behavior | 1976 |
Comparison of putative dopamine receptors in blood vessels and the central nervous system.
Topics: Amantadine; Amphetamine; Animals; Aporphines; Arteries; Brain; Chlorpromazine; Dogs; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Kidney; Piribedil; Receptors, Drug; Thioridazine; Trifluoperazine; Tyramine | 1975 |
On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
Topics: 5-Hydroxytryptophan; Amantadine; Amphetamine; Animals; Apomorphine; Dopamine; Levodopa; Male; Mice; Pentylenetetrazole; Seizures; Serotonin | 1979 |
Influence of the time interval after venepuncture and the storage temperature on the uptake of 14C-serotonin by human blood platelets.
Topics: Amantadine; Amphetamine; Biological Transport; Blood Platelets; Blood Preservation; Cell Survival; Humans; Kinetics; Serotonin; Temperature | 1977 |
Ultrastructural evidence of amantadine and amphetamine noradrenaline releasing action.
Topics: Adrenal Medulla; Amantadine; Amphetamine; Animals; Depression, Chemical; Dose-Response Relationship, Drug; Norepinephrine; Rats; Time Factors | 1977 |
Effects of catecholaminergic drugs on systems of reward and punishment in experiments on cats.
Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Benserazide; Catecholamines; Cats; Disulfiram; Electric Stimulation; Electrodes, Implanted; Levodopa; Male; Punishment; Reward | 1976 |
Some behavioural changes induced by amantadine (adamantine).
Topics: Amantadine; Amphetamine; Analgesia; Animals; Exploratory Behavior; Female; Male; Mice; Muscles; Rats; Tetrazoles | 1976 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; Levodopa; Male; Methysergide; Middle Aged; Movement Disorders; Myoclonus; Parkinson Disease; Propranolol; Serotonin; Serotonin Antagonists; Sleep; Trihexyphenidyl | 1975 |
Responses of central neurones to amantadine: comparison with dopamine and amphetamine.
Topics: Amantadine; Amphetamine; Animals; Caudate Nucleus; Cerebral Cortex; Depression, Chemical; Dopamine; Electrophysiology; Iontophoresis; Neurons; Rats | 1975 |
Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Catechols; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Methyltyrosines; Rats; Tritium; Tyrosine | 1975 |
Proceedings: Responses of cortical pyramidal tract cells to amantadine and amphetamine after depletion of central catecholamines.
Topics: Amantadine; Amphetamine; Animals; Brain Chemistry; Catecholamines; Dopamine; Male; Norepinephrine; Pyramidal Tracts; Rats | 1975 |
Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benztropine; Brain; Dopamine; Levodopa; Male; Rats; Stimulation, Chemical | 1975 |
Attenuation of pentylenetetrazol kindling of epileptogenesis in rats by dopaminergic agents.
Topics: Amantadine; Amphetamine; Animals; Epilepsy; Haloperidol; Kindling, Neurologic; Levodopa; Male; Metoclopramide; Pentylenetetrazole; Rats | 1988 |
Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hydroxydopamines; Male; Mice; Neurochemistry; Norepinephrine; Serotonin; Time Factors | 1973 |
A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
Topics: Amantadine; Amphetamine; Animals; Brain; Dextroamphetamine; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Hydrazines; Isomerism; Male; Methyltyrosines; Mice; Motor Activity; Norepinephrine; Receptors, Drug; Stimulation, Chemical; Time Factors | 1972 |
On the nature of the adrenergic neuron extragranular amine binding site.
Topics: Amantadine; Amphetamine; Animals; Binding Sites; Biogenic Amines; Dopamine; Female; Guanethidine; Hydrazines; Hydroxydopamines; Myocardium; Norepinephrine; Normetanephrine; Octopamine; Phenoxybenzamine; Rats; Receptors, Adrenergic; Reserpine; Tetrabenazine; Tritium; Tyramine | 1974 |
Dopamine and noradrenaline transport into subcellular vesicles of the striatum.
Topics: Adenosine Triphosphate; Amantadine; Amphetamine; Animals; Basal Ganglia; Brain Chemistry; Carbon Isotopes; Corpus Striatum; Desipramine; Dopamine; Magnesium; Norepinephrine; Swine; Temperature | 1973 |
Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Caudate Nucleus; Dextroamphetamine; Dioxoles; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Humans; Injections; Male; Methylphenidate; Motor Activity; Nialamide; Piperazines; Pyrimidines; Rats; Stereotyped Behavior; Sulfites | 1974 |
On the mode of action of amantadine.
Topics: Amantadine; Amphetamine; Animals; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Methyltyrosines; Mice; Motor Activity; Myocardium; Nialamide | 1970 |
The relationship between the inhibition of dopamine uptake and the enhancement of amphetamine stereotypy.
Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Chlorpheniramine; Dopamine; Dopamine Antagonists; Drug Synergism; Histamine H1 Antagonists; Injections, Intraperitoneal; Male; Orphenadrine; Parasympatholytics; Parkinson Disease; Piperidines; Rats; Trihexyphenidyl | 1971 |
Effects of amantadine on uptake and release of dopamine by a particulate fraction of rat basal ganglia.
Topics: Amantadine; Amphetamine; Animals; Basal Ganglia; Dopamine; In Vitro Techniques; Parasympatholytics; Rats; Synaptosomes | 1972 |
Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Body Temperature; Chlorpromazine; Corpus Striatum; Dopamine; Male; Rats; Time Factors; Tritium; Tyrosine | 1974 |
The effect of delta9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosoma; preparations.
Topics: Amantadine; Amphetamine; Animals; Cannabis; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Dronabinol; Ephedrine; Male; Mice; Pargyline; Synaptosomes | 1974 |
Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
Topics: Amantadine; Amphetamine; Animals; Brain; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; In Vitro Techniques; Kinetics; Male; Nerve Endings; Norepinephrine; Rats; Synaptic Vesicles; Synaptosomes; Tritium | 1973 |
Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
Topics: Amantadine; Amphetamine; Animals; Cats; Caudate Nucleus; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Electric Stimulation; Female; Male; Neurons; Norepinephrine; Organ Size; Perfusion; Serotonin; Substantia Nigra; Tritium; Tyramine | 1973 |
The effect of amantadine and (+)-amphetamine on motility in rats after inhibition of monoamine synthesis and storage.
Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Catecholamines; Drug Synergism; Female; Locomotion; Methyltyrosines; Rats; Reserpine | 1973 |
Effects of amantadine and amphetamine on serotonin uptake and release by human blood platelets.
Topics: Amantadine; Amphetamine; Blood Platelets; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Kinetics; Serotonin; Serotonin Antagonists; Time Factors; Tritium | 1973 |
Effect of amantadine on cerebral acetylcholine release and content in the guinea pig.
Topics: Acetylcholine; Amantadine; Amphetamine; Animals; Behavior, Animal; Brain; Brain Chemistry; Brain Stem; Caudate Nucleus; Cerebral Cortex; Female; Guinea Pigs; In Vitro Techniques; Male; Methyltyrosines; Reserpine; Time Factors | 1973 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain Chemistry; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Hydroxydopamines; Methylphenidate; Methyltyrosines; Rats; Reserpine; Scopolamine | 1973 |
[Experimental and clinical data on the mechanism of action of amantadine and on its effectiveness in Parkinson's disease].
Topics: Acetylcholine; Aged; Amantadine; Amphetamine; Animals; Brain; Female; Guinea Pigs; Humans; Male; Middle Aged; Parkinson Disease; Tyrosine | 1971 |
Central effects of 6-hydroxydopamine.
Topics: Amantadine; Amitriptyline; Amphetamine; Animals; Behavior, Animal; Brain; Brain Chemistry; Desipramine; Dopamine; Electroencephalography; Female; Humans; Hydroxydopamines; Imipramine; Male; Mice; Motor Activity; Norepinephrine; Rats; Seizures; Species Specificity; Stereotyped Behavior | 1971 |
Role of the relationships between the neurotransmitter systems in the convulsive-seizure reactions.
Topics: 5-Hydroxytryptophan; Amantadine; Amphetamine; Animals; Dopamine; Electroshock; gamma-Aminobutyric Acid; Kindling, Neurologic; Levodopa; Mice; Neurotransmitter Agents; Rats; Seizures; Serotonin | 1982 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
Uptake of 14C-tyramine and release of extravesicular 3H-noradrenaline in isolated perfused rabbit hearts.
Topics: Amantadine; Amphetamine; Animals; Cocaine; Corticosterone; Female; In Vitro Techniques; Kinetics; Male; Myocardium; Norepinephrine; Rabbits; Sodium; Tyramine | 1983 |
Supersensitivity following repeated administration of dopaminergic agonists.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Cocaine; Dopamine; Exploratory Behavior; Female; Humans; Motor Activity; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1982 |
[Effect of the stimulators and inhibitors of the central dopaminergic structures on the kininogen level and kallikrein activity in the rat plasma].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Chlorpromazine; Haloperidol; Kallikreins; Kininogens; Male; Rats; Receptors, Dopamine; Reserpine | 1980 |
Novel synergistic treatment of ethanol withdrawal seizures in rats with dopamine and serotonin agonists.
Topics: Alcohol Withdrawal Delirium; Amantadine; Amphetamine; Animals; Chlordiazepoxide; Dopamine Agonists; Drug Synergism; Drug Therapy, Combination; Fenfluramine; Male; Pyrimidines; Rats; Serotonin Receptor Agonists | 1995 |
Desipramine and amantadine causing false-positive urine test for amphetamine.
Topics: Adult; Amantadine; Amphetamine; Cocaine; Desipramine; False Positive Reactions; Humans; Male; Substance Abuse Detection | 1993 |
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.
Topics: Adolescent; Adult; Amantadine; Amphetamine; Analysis of Variance; Blood Pressure; Bromocriptine; Dopamine Agonists; Double-Blind Method; Heart Rate; Humans; Male; Pergolide; Psychomotor Performance; Reflex, Startle; Time Factors | 2002 |
The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central alpha1-adrenergic system in rats.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Agonists; Aggression; Amantadine; Amphetamine; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Binding, Competitive; Cerebral Cortex; Clonidine; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Hyperkinesis; Imipramine; Male; Motor Activity; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1 | 2004 |
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Amantadine; Amphetamine; Animals; Atomoxetine Hydrochloride; Brain Injuries, Traumatic; Central Nervous System Stimulants; Chronic Disease; Disease Models, Animal; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Frontal Lobe; Male; Motor Activity; Neuroimmunomodulation; Rats, Long-Evans; Severity of Illness Index | 2016 |